Get latest articles and stories on Latest News at LatestLY. Glenmark Pharmaceuticals on Wednesday reported a net loss of Rs 351 crore on a consolidated basis for the third quarter ended December 31, 2023. Latest News | Glenmark Reports Net Loss of Rs 351 Cr in Q3 on Lower Domestic Sales.
Glenmark Pharmaceuticals and Ichnos Sciences have formed an alliance called Ichnos Glenmark Innovation (IGI) to accelerate cancer drug discovery. The alliance combines Glenmark s expertise in small molecules with Ichnos proficiency in novel biologics. They are developing therapy solutions for hematological malignancies and solid tumors, with three innovative oncology molecules currently in clinical trials.
Get latest articles and stories on Latest News at LatestLY. Glenmark Pharmaceuticals Ltd and Ichnos Sciences Inc announced an alliance to accelerate new drug discovery in cancer treatment. Latest News | Glenmark, Ichnos Sciences Form Alliance for New Drug Discovery in Cancer Treatment.